Market Cap 15.30M
Revenue (ttm) 0.00
Net Income (ttm) -96.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 177,617
Avg Vol 524,202
Day's Range N/A - N/A
Shares Out 39.04M
Stochastic %K 80%
Beta 3.00
Analysts Hold
Price Target $0.40

Company Profile

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 620 8501
Address:
18706 North Creek Parkway, Suite 104, Bothell, United States
11thestate
11thestate Aug. 13 at 11:15 AM
$ATHA has agreed to a $10 million settlement with investors to resolve claims that the company misled them regarding research integrity. Who’s eligible? Anyone who bought and held $ATHA stock between September 17, 2020, and June 17, 2021. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $0.47 — but if only ~25% of eligible investors file, the effective payout could increase to $1.88 per share. Can I still file? Yes — late claims are currently being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08122025_1
0 · Reply
d_risk
d_risk Aug. 8 at 12:45 PM
$ATHA - Athira Pharma Inc. Common Stock - 10Q - Updated Risk Factors ATHA’s risk factors now center on total reliance on ATH-1105 for ALS after halting fosgonimeton, with heightened warnings on clinical, regulatory, and commercialization hurdles, cash burn, IP and litigation threats, strategic transaction risks, and new disclosures on data privacy, cybersecurity, and market volatility. #Pharmaceuticals #CashBurn #RegulatoryChallenges #ClinicalRisk #ALSTreatment 🟢 Added 🟠 Removed https://d-risk.ai/ATHA/10-Q/2025-08-07
0 · Reply
JamesBenz401
JamesBenz401 Aug. 4 at 10:06 PM
$ATHA only has until October 13 2025 for compliance . Does this sound correct? Hope we don’t get R/S
0 · Reply
PPalisades
PPalisades Aug. 1 at 4:10 PM
$ATHA added 1000
0 · Reply
11thestate
11thestate Aug. 1 at 11:05 AM
Took a hit on $ATHA? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=dailyposts&utm_content=08012025_1 #ATHA
0 · Reply
11thestate
11thestate Jul. 24 at 12:15 PM
$ATHA losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/athira-ipo-spo-settlement #Athira #ATHA
0 · Reply
Stock_Catcher
Stock_Catcher Jul. 23 at 12:56 AM
Money Wednesday Part 9 $ATHA $TLSA $GSIW $NEOV $OBIO Let's Do Well Tomorrow
1 · Reply
Profitrip
Profitrip Jul. 22 at 8:33 PM
0 · Reply
stockanalysis_
stockanalysis_ Jul. 16 at 8:46 PM
After Hours Gainers: $SRPT $YOSH $FTRK $BLMZ $ATHA View the entire list here: https://stockanalysis.com/markets/afterhours/gainers/?ref=saveontrading
1 · Reply
11thestate
11thestate Jul. 15 at 1:04 PM
$ATHA investors — there’s a potential path to recover losses. It’s worth a look: https://11th.com/cases/athira-ipo-spo-settlement #Athira #ATHA
0 · Reply
Latest News on ATHA
Athira Pharma to Participate in Upcoming June Conferences

May 29, 2024, 7:00 AM EDT - 1 year ago

Athira Pharma to Participate in Upcoming June Conferences


Athira Pharma to Participate in Upcoming May Conferences

May 2, 2024, 7:00 AM EDT - 1 year ago

Athira Pharma to Participate in Upcoming May Conferences


Athira Pharma Provides 2023 Pipeline Outlook

Jan 5, 2023, 7:00 AM EST - 2 years ago

Athira Pharma Provides 2023 Pipeline Outlook


11thestate
11thestate Aug. 13 at 11:15 AM
$ATHA has agreed to a $10 million settlement with investors to resolve claims that the company misled them regarding research integrity. Who’s eligible? Anyone who bought and held $ATHA stock between September 17, 2020, and June 17, 2021. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $0.47 — but if only ~25% of eligible investors file, the effective payout could increase to $1.88 per share. Can I still file? Yes — late claims are currently being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08122025_1
0 · Reply
d_risk
d_risk Aug. 8 at 12:45 PM
$ATHA - Athira Pharma Inc. Common Stock - 10Q - Updated Risk Factors ATHA’s risk factors now center on total reliance on ATH-1105 for ALS after halting fosgonimeton, with heightened warnings on clinical, regulatory, and commercialization hurdles, cash burn, IP and litigation threats, strategic transaction risks, and new disclosures on data privacy, cybersecurity, and market volatility. #Pharmaceuticals #CashBurn #RegulatoryChallenges #ClinicalRisk #ALSTreatment 🟢 Added 🟠 Removed https://d-risk.ai/ATHA/10-Q/2025-08-07
0 · Reply
JamesBenz401
JamesBenz401 Aug. 4 at 10:06 PM
$ATHA only has until October 13 2025 for compliance . Does this sound correct? Hope we don’t get R/S
0 · Reply
PPalisades
PPalisades Aug. 1 at 4:10 PM
$ATHA added 1000
0 · Reply
11thestate
11thestate Aug. 1 at 11:05 AM
Took a hit on $ATHA? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=dailyposts&utm_content=08012025_1 #ATHA
0 · Reply
11thestate
11thestate Jul. 24 at 12:15 PM
$ATHA losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/athira-ipo-spo-settlement #Athira #ATHA
0 · Reply
Stock_Catcher
Stock_Catcher Jul. 23 at 12:56 AM
Money Wednesday Part 9 $ATHA $TLSA $GSIW $NEOV $OBIO Let's Do Well Tomorrow
1 · Reply
Profitrip
Profitrip Jul. 22 at 8:33 PM
0 · Reply
stockanalysis_
stockanalysis_ Jul. 16 at 8:46 PM
After Hours Gainers: $SRPT $YOSH $FTRK $BLMZ $ATHA View the entire list here: https://stockanalysis.com/markets/afterhours/gainers/?ref=saveontrading
1 · Reply
11thestate
11thestate Jul. 15 at 1:04 PM
$ATHA investors — there’s a potential path to recover losses. It’s worth a look: https://11th.com/cases/athira-ipo-spo-settlement #Athira #ATHA
0 · Reply
SandmanWasHere
SandmanWasHere Jul. 10 at 3:30 PM
$ATHA closing some at 50% 💪
0 · Reply
JamesBenz401
JamesBenz401 Jul. 10 at 2:08 PM
$ATHA why and what?? Been here a long time @.80
0 · Reply
Ron_Burn
Ron_Burn Jul. 9 at 6:06 PM
0 · Reply
BULLETSTOCK
BULLETSTOCK Jul. 8 at 4:26 PM
$ATHA Getting ready $$$$$$$$$$$$$$$$$$$ Watching $ICU $RLYB
0 · Reply
11thestate
11thestate Jul. 7 at 4:15 PM
The one thing no one’s telling you about $ATHA. Spoiler: it might be the only thing that actually makes you thousands. #AthiraPharma #ATHA ➡️ https://11th.com/cases/athira-ipo-spo-settlement
0 · Reply
117Cavanaugh
117Cavanaugh Jul. 7 at 4:06 PM
$ATHA Any hope for a recovery back to $1 for this?
1 · Reply
ZhaoSonsWealth
ZhaoSonsWealth Jul. 6 at 11:00 PM
0 · Reply
intrader
intrader Jul. 3 at 4:36 PM
$ATHA I'm in.
0 · Reply
intrader
intrader Jul. 3 at 4:35 PM
0 · Reply
Zinvest
Zinvest Jul. 3 at 4:04 PM
$ATHA Exploding! Sweet! Buying my $TSLA soon!
0 · Reply
Zinvest
Zinvest Jul. 3 at 4:00 PM
$ATHA Excellent!
0 · Reply
somaopp
somaopp Jun. 30 at 6:17 PM
$ATHA RS due in Oct?
0 · Reply